Failures in Clinical Trials in the European Union: Lessons from the Polish Experience

Science and Engineering Ethics 19 (3):1087-1098 (2013)
Download Edit this record How to cite View on PhilPapers
When discussing the safety of research subjects, including their exploitation and vulnerability as well as failures in clinical research, recent commentators have focused mostly on countries with low or middle-income economies. High-income countries are seen as relatively safe and well-regulated. This article presents irregularities in clinical trials in an EU member state, Poland, which were revealed by the Supreme Audit Office of Poland (the NIK). Despite adopting many European Union regulations, including European Commission directives concerning Good Clinical Practice, these irregularities occurred. Causes as well as potential solutions to make clinical trials more ethical and safer are discussed
(categorize this paper)
PhilPapers/Archive ID
Upload history
Archival date: 2015-11-21
View other versions
Added to PP index

Total views
221 ( #32,219 of 69,074 )

Recent downloads (6 months)
13 ( #50,415 of 69,074 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.